Analytic for Hemodynamic Instability (AHI) vs Tempus ECG-AF
AI Verdict
Choose Analytic for Hemodynamic Instability (AHI) if…
Choose Analytic for Hemodynamic Instability (AHI) if your primary need is continuous, real-time monitoring of adult in-hospital patients to detect early signs of hemodynamic instability. This tool is ideal for critical care or general ward settings where proactive intervention based on predictive analytics can prevent acute patient deterioration hours before traditional vital signs would indicate a problem.
View Analytic for Hemodynamic Instability (AHI) →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your goal is to identify older patients (65+) at increased risk of developing new-onset atrial fibrillation within the next year. This solution is best suited for screening programs or routine cardiology assessments to enable earlier intervention and management strategies for AF prevention in at-risk populations.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Analytic for Hemodynamic Instability (AHI) | Tempus ECG-AF |
|---|---|---|
| Pricing | Unknown | Contact vendor |
| Deployment | Integrates with existing hospital ECGs and can be deployed through platforms like Medical Informatics Corp.'s Sickbay™ and VitalConnect's remote patient monitoring solution. | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Analytic for Hemodynamic Instability (AHI)Tool A explicitly highlights user-friendly visual indicators (red, yellow, green) and aims to reduce nurse surveillance burden and streamline workflow, directly addressing ease of use for clinical staff. Its accessibility via any browser-enabled device further enhances its practical usability in a hospital setting. Tool B's description focuses more on integration and diagnostic interpretation rather than direct user interaction ease.
Clinical Value
Analytic for Hemodynamic Instability (AHI)While both tools offer significant clinical value, Tool A's ability to provide early warnings (up to 26 hours for AHI-PI) for acute, life-threatening hemodynamic instability directly impacts immediate patient safety and allows for proactive intervention in critical care settings. Tool B focuses on long-term risk prediction for a chronic condition, which is valuable for preventative care but less immediate in its impact on acute patient outcomes.
Pricing & Value
Tempus ECG-AFTool B offers clear information regarding CMS reimbursement availability (CPT 0764T and CPT 0765T to APC 5734) and a specific Medicare rate of $128.90, effective January 1, 2025. This transparency and established reimbursement pathway significantly enhance its financial value proposition for healthcare providers. Tool A provides no specific pricing or reimbursement details, requiring direct vendor contact.
Enterprise Readiness
Tempus ECG-AFBoth tools are FDA-cleared Software as a Medical Device (SaMD) designed for integration into healthcare facility systems. However, Tool B explicitly confirms HIPAA compliance and BAA availability ('has_baa: yes', 'hipaa_compliant: yes'), providing greater assurance for enterprise deployment compared to Tool A's 'likely, contact vendor for details' statements. Both integrate with major monitoring/ECG systems.
Innovation
Analytic for Hemodynamic Instability (AHI)Tool A's continuous, real-time predictive monitoring for an acute, rapidly evolving condition like hemodynamic instability, hours in advance, using continuous ECG lead II data, represents a more dynamic and advanced application of AI in immediate clinical decision support. Tool B's single-ECG, 12-month risk prediction for AF is valuable but less focused on real-time, acute patient deterioration.
Support & Docs
Tempus ECG-AFTempus (Tool B) provides clear and accessible contact information for customer and technical support, including specific email addresses ([email protected], [email protected]) and phone numbers (800.739.4137) for inquiries related to their cardiology products. While Fifth Eye (Tool A) was acquired by AirStrip in June 2025, and AirStrip offers a 'Technical Support Form', direct and specific support details for AHI itself are less transparently published.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Analytic for Hemodynamic Instability (AHI) | Tempus ECG-AF |
|---|---|---|
| Primary Purpose/Target Condition | Continuously monitors adult in-hospital patients for signs of hemodynamic instability, providing early warnings. | Analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. |
| Input Data Type | Continuous ECG lead II data. | 12-lead ECG recordings. |
| Target Patient Population | Adult in-hospital patients. | Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. |
| Prediction Horizon | Predicts hemodynamic instability earlier than vital signs (up to 26 hours for AHI-PI). | Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months. |
| Key Specialties | Cardiology, Critical Care, Emergency Medicine | Cardiology, Geriatrics, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Analytic for Hemodynamic Instability (AHI) and Tempus ECG-AF.